PNC Financial Services Group’s ClearPoint Neuro CLPT Stock Holding History

PNC Financial Services Group’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.4K	Sell	4,000 -5	-0.1%	-$62	﹤0.01%	3133
2026 Q1	$36.4K	Buy	4,005 +5	+0.1%	+$63	﹤0.01%	3399
2025 Q4	$54.7K	Hold	4,000	–	–	﹤0.01%	3159
2025 Q3	$87.2K	Hold	4,000	–	–	﹤0.01%	2898
2025 Q2	$47.8K	Buy	+4,000	New	+$50.3K	﹤0.01%	3139
2022 Q1	–	Sell	-1,000	Closed	-$11K	–	4542
2021 Q4	$11K	Sell	1,000 -1,000	-50%	-$15K	﹤0.01%	3752
2021 Q3	$36K	Hold	2,000	–	–	﹤0.01%	3248
2021 Q2	$38K	Hold	2,000	–	–	﹤0.01%	3207
2021 Q1	$42K	Buy	+2,000	New	+$42.8K	﹤0.01%	3074

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CCM

Conway Capital Management Burbank, California $225M AUM 19.09% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PNC Financial Services Group's CLPT Position: Q2 2026 in Review

PNC Financial Services Group reduced its ClearPoint Neuro (CLPT) stake by 0.12% in Q2 2026, selling an estimated $62 and leaving 4,000 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

PNC Financial Services Group first reported a position in CLPT in Q1 2021 and has held it in 9 quarters since. The position peaked at $87.2K in Q3 2025. 49 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

PNC Financial Services Group held 4,000 shares of ClearPoint Neuro worth $71.4K as of Q2 2026.
PNC Financial Services Group sold 5 ClearPoint Neuro shares in Q2 2026, an estimated $62.
ClearPoint Neuro made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3133 holding.
PNC Financial Services Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 9 quarters since.
PNC Financial Services Group's ClearPoint Neuro position peaked at $87.2K in Q3 2025.
49 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.